Dr. Schoenberger is a translational immunologist working in the area of precision cancer immunotherapy. He is a professor in the Center for Cancer Immunotherapy at the La Jolla institute for Immunology and Adjunct Professor of Medicine in the Division of Hematology and Oncology at the UC San Diego Moores Cancer Center.
Anixa Biosciences Initiates Dosing in Third Cohort in its Ovarian Cancer CAR-T Clinical Trial
Read More...Anixa Biosciences and Cleveland Clinic Present New Updated Positive Data from Phase 1 Study of Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting
Read More...Anixa Biosciences Announces Timing of Public Release of Data from the Phase 1 Study of its Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting
Read More...